Drugs & TargetsFree FDA grants QIDP and Fast Track Designations to Cidara September 28, 2018Vol.44 No.36
Drugs & TargetsFree Blincyto approved In Japan for relapsed or refractory B-cell ALL September 28, 2018Vol.44 No.36
Drugs & Targets European Commission approves Braftovi + Mektovi for advanced BRAF-mutant melanoma September 21, 2018Vol.44 No.35
Drugs & Targets OBI Pharma granted Orphan Drug Designation for treatment of ALL September 21, 2018Vol.44 No.35
Drugs & TargetsFree FDA approves moxetumomab pasudotox-tdfk for hairy cell leukemia September 14, 2018Vol.44 No.34
Drugs & TargetsFree Boehringer Ingelheim acquires all ViraTherapeutics shares to develop next-gen viral-based therapies September 14, 2018Vol.44 No.34
Drugs & Targets Kymriah gets European approval for B-cell ALL and diffuse large B-cell lymphoma indications September 07, 2018Vol.44 No.33
Drugs & Targets FDA gives priority review to BMS Empliciti + pomalidomide, dexamethasone in multiple myeloma September 07, 2018Vol.44 No.33
